30 Apr Atai Life Sciences Is Betting BIG On The Shift In Psychedelics To Treat Mental Illness
Posted at 11:58h in Podcast
2020 has been a tough year for global markets and this is a trend that we have been closely following. During the last year, we have seen a rapid increase in the number of companies that are in the psychedelic market and this is a vertical that we have become excited about.
Read full article: https://demerx.com/wp-content/uploads/2020/06/Atai-Life-Sciences-Is-Betting-BIG-On-The-Shift-In-Psychedelics-To-Treat-Mental-Illness-Mushroomstocks-_-Mushroomstocks.pdf